ConsensusCurrent

FDA-approved prescribing information — Elitek rasburicase prescribing information: safety and specimen handling

FDA-approved prescribing information, 2026

Do not administer with G6PD deficiency; screen higher-risk patients before use. Permanently stop for hemolysis/methemoglobinemia or serious hypersensitivity. Urate sampling requires chilled heparin tubes, ice-water transport, cooled processing and plasma assay within four hours.

Expert opinionLow certainty

View source guideline

Clinical Context & Relevant Topics (1)

Disease Reference

Tumor Lysis Syndrome

Risk-stratified prevention and ICU treatment of tumor lysis syndrome with hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia and AKI.

View Topic Context →